Service of Clinical Pharmacology, University Hospital Lausanne, Lausanne, Switzerland.
Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
J Antimicrob Chemother. 2021 Feb 11;76(3):758-764. doi: 10.1093/jac/dkaa505.
The extent of inappropriate prescribing observed in geriatric medicine has not been thoroughly evaluated in people ageing with HIV. We determined the prevalence of and risk factors for inappropriate prescribing in individuals aged ≥75 years enrolled in the Swiss HIV Cohort Study.
Retrospective review of medical records was performed to gain more insights into non-HIV comorbidities. Inappropriate prescribing was screened using the Beers criteria, the STOPP/START criteria and the Liverpool drug-drug interactions (DDIs) database.
For 175 included individuals, the median age was 78 years (IQR 76-81) and 71% were male. The median number of non-HIV comorbidities was 7 (IQR 5-10). The prevalence of polypharmacy and inappropriate prescribing was 66% and 67%, respectively. Overall, 40% of prescribing issues could have deleterious consequences. Prescribing issues occurred mainly with non-HIV drugs and included: incorrect dosage (26%); lack of indication (21%); prescription omission (drug not prescribed although indicated) (17%); drug not appropriate in elderly individuals (18%) and deleterious DDIs (17%). In the multivariable logistic regression, risk factors for prescribing issues were polypharmacy (OR: 2.5; 95% CI: 1.3-4.7), renal impairment (OR: 2.7; 95% CI: 1.4-5.1), treatment with CNS-active drugs (OR: 2.1; 95% CI: 1.1-3.8) and female sex (OR: 8.3; 95% CI: 2.4-28.1).
Polypharmacy and inappropriate prescribing are highly prevalent in elderly people living with HIV. Women are at higher risk than men, partly explained by sex differences in the occurrence of non-HIV comorbidities and medical care. Medication reconciliation and periodic review of prescriptions by experienced physicians could help reduce polypharmacy and inappropriate prescribing in this vulnerable, growing population.
在老年医学中,观察到的不适当处方的程度在与 HIV 一起衰老的人群中尚未得到彻底评估。我们确定了在瑞士艾滋病毒队列研究中纳入的年龄≥75 岁的个体中不适当处方的流行程度和危险因素。
回顾性审查病历以更深入地了解非 HIV 合并症。使用 Beers 标准、STOPP/START 标准和利物浦药物相互作用 (DDI) 数据库筛查不适当的处方。
对于 175 名纳入的个体,中位年龄为 78 岁(IQR 76-81),71%为男性。非 HIV 合并症的中位数为 7(IQR 5-10)。多药治疗和不适当处方的患病率分别为 66%和 67%。总体而言,40%的处方问题可能产生有害后果。处方问题主要发生在非 HIV 药物上,包括:剂量不正确(26%);缺乏适应症(21%);处方遗漏(尽管有适应症但未开处方)(17%);不适合老年患者的药物(18%)和有害的 DDI(17%)。在多变量逻辑回归中,处方问题的危险因素是多药治疗(OR:2.5;95%CI:1.3-4.7)、肾功能损害(OR:2.7;95%CI:1.4-5.1)、使用 CNS 活性药物(OR:2.1;95%CI:1.1-3.8)和女性(OR:8.3;95%CI:2.4-28.1)。
在 HIV 感染者中,老年人中普遍存在多药治疗和不适当处方。女性比男性的风险更高,部分原因是女性的非 HIV 合并症和医疗护理的性别差异。通过经验丰富的医生进行药物调整和定期审查处方,可以帮助减少这个脆弱、不断增长的人群中的多药治疗和不适当处方。